Page 18 - உலகளாவிய சந்தைப்படுத்தல் இயக்குனர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

26 gennaio 2021 MONTREAL, Jan. 26, 2021 /PRNewswire/  Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to announce its new corporate name, CellCarta, and brand identity. The new name for the Montreal-headquartered company stems from the 2019 combination of contract research organization Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a provider of histopathology and genomics services based in Antwerp. Recently, CellCarta further expanded its scientific capabilities and geographic presence through the acquisitions of Nova Scotia-based Clinical Logistics Inc. and California-based Mosaic Laboratories LLC. As a result, CellCarta is well positioned to serve the global clinical trial requirements of its pharmaceutical and bio-tech clients with state-of-the-art facilities in the United States, Canada, Europe and China.  CellCarta is backed by A

United statesCaprion biosciencesMartin leblancGuylaine galipeauNick wrightDavid spaightKristen duarteArsenal strategic company buildingNova clinical logistics incMosaic laboratoriesNova scotia based clinical logisticsCalifornia based mosaic laboratoriesArsenal capitalMagna cartaExecutive chairmanArsenal operating partner